<!DOCTYPE html>
<html lang="en-US">
<head>
  <meta http-equiv="content-type" content="text/html; charset=UTF-8" />
  <meta name="generator" content="Madoko, version 1.2.3" />
  <meta name="viewport" content="initial-scale=1.0" />
  <meta name="author" content="Dr. Jagdish Varma" />
  <title>Managing Bipolar in a Woman of Child Bearing Potential</title>
  <style type="text/css"  class="link">
  /*# sourceURL=madoko.css */
  
  .madoko .toc>.tocblock .tocblock .tocblock {
    margin-left: 2.25em;
  }
  .madoko .toc>.tocblock .tocblock {
    margin-left: 1.5em;
  }
  .madoko .toc-contents>.tocblock>.tocitem {
    font-weight: bold;
  }
  .madoko .toc {
    margin-top: 1em;
  }
  .madoko p.para-continue {
    margin-bottom: 0pt;
  }
  .madoko .para-block+p {
    margin-top: 0pt;
  }
  .madoko ul.para-block, .madoko ol.para-block {
    margin-top: 0pt;
    margin-bottom: 0pt;
  }
  .madoko ul.para-end, .madoko ol.para-end {
    margin-bottom: 1em;
  }
  .madoko dl {
    margin-left: 0em;
  }
  .madoko blockquote {
    font-style: italic;
  }
  .madoko a.localref {
    text-decoration: none;
  }
  .madoko a.localref:hover {
    text-decoration: underline;
  }
  .madoko .footnotes {
    font-size: smaller;
    margin-top: 2em;
  }
  .madoko .footnotes hr {
    width: 50%;
    text-align: left;
  }
  .madoko .footnote {
    margin-left: 1em;
  }
  .madoko .footnote-before {
    margin-left: -1em;
    width: 1em;
    display: inline-block;
  }
  .madoko .align-center, .madoko .align-center>p {
    text-align: center !important;
  }
  .madoko .align-center pre {
    text-align: left;
  }
  .madoko .align-center>* {
    margin-left: auto !important;
    margin-right: auto !important;
  }
  .madoko .align-left, .madoko .align-left>p {
    text-align: left !important;
  }
  .madoko .align-left>* {
    margin-left: 0pt !important;
    margin-right: auto !important;
  }
  .madoko .align-right, .madoko .align-right>p {
    text-align: right !important;
  }
  .madoko .align-right>* {
    margin-left: auto !important;
    margin-right: 0pt !important;
  }
  .madoko .align-center>table,
  .madoko .align-left>table,
  .madoko .align-right>table {
    text-align: left !important;
  }
  .madoko .equation-before {
    float: right;
  }
  .madoko .bibitem {
    font-size: smaller;
  }
  .madoko .bibsearch {
    font-size: x-small;
    text-decoration:none;
    color: black;
    font-family: "Segoe UI Symbol", Symbola, serif;
  }
  .madoko .block, .madoko .figure, .madoko .bibitem, .madoko .equation, .madoko div.math {
    margin-top: 1ex;
    margin-bottom: 1ex;
  }
  .madoko .figure {
    padding: 0.5em;
    margin-left: 0pt;
    margin-right: 0pt;
  }
  .madoko .hidden {
    display: none;
  }
  .madoko .invisible {
    visibility: hidden;
  }
  .madoko.preview .invisible {
    visibility: visible;
    opacity: 0.5;
  }
  .madoko code.code, .madoko span.code {
    white-space: pre-wrap;
  }
  .madoko hr, hr.madoko {
    border: none;
    border-bottom: black solid 1px;
    margin-bottom: 0.5ex;
  }
  .madoko .framed>*:first-child {
    margin-top: 0pt;
  }
  .madoko .framed>*:last-child {
    margin-bottom: 0pt;
  }
  .madoko ul.list-style-type-dash {
      list-style-type: none !important;
  }
  .madoko ul.list-style-type-dash > li:before {
      content: "\2013";
      position: absolute;
      margin-left: -1em;
  }
  .madoko table.madoko {
    border-collapse: collapse;
  }
  .madoko td, .madoko th {
    padding: 0ex 0.5ex;
    margin: 0pt;
    vertical-align: top;
  }
  .madoko .cell-border-left {
    border-left: 1px solid black;
  }
  .madoko .cell-border-right {
    border-right: 1px solid black;
  }
  .madoko thead>tr:first-child>.cell-line,
  .madoko tbody:first-child>tr:first-child>.cell-line {
    border-top: 1px solid black;
    border-bottom: none;
  }
  .madoko .cell-line, .madoko .cell-double-line {
    border-bottom: 1px solid black;
    border-top: none;
  }
  .madoko .cell-double-line {
    border-top: 1px solid black;
    padding-top: 1.5px !important;
  }
  .madoko .input-mathpre .MathJax_Display {
    text-align: left !important;
  }
  .madoko div.input-mathpre {
    text-align: left;
    margin-top: 1.5ex;
    margin-bottom: 1ex;
  }
  .madoko .math-rendering {
    text-align: left;
    white-space: pre;
    color: gray;
  }
  .madoko .mathdisplay {
    text-align: center;
  }
  .madoko span.math-rendering {
    display:inline-block;
    width:8em;
    overflow-x:auto;
    font-size:70%;
  }
  .madoko span.math-rendering::-webkit-scrollbar {
    width:4px;
  }
  .madoko .pretty table {
    border-collapse: collapse;
  }
  .madoko .pretty td {
    padding: 0em;
  }
  .madoko .pretty td.empty {
    min-width: 1.5ex;
  }
  .madoko .pretty td.expander {
    width: 100em;
  }
  body.madoko, .madoko .serif {
    font-family: Cambria,"Times New Roman","Liberation Serif","Times",serif;
  }
  .madoko .sans-serif {
    font-family: "Calibri", "Optima", sans-serif;
  }
  .madoko .symbol {
    font-family: "Segoe UI Symbol", Symbola, serif;
  }
  body.madoko {
    -webkit-text-size-adjust: 100%;       
    text-rendering: optimizeLegibility;
  }
  body.madoko {
    max-width: 88ex; 
    margin: 1em auto;
    padding: 0em 2em;
  }
  body.preview.madoko {
    padding: 0em 1em;
  }
  .madoko p {
    text-align: justify;
  }
  .madoko h1, .madoko h2, .madoko h3, .madoko h4 {
    margin-top: 1.22em;
    margin-bottom: 1ex;
  }
  .madoko h1+p, .madoko h2+p, .madoko h3+p, .madoko h4+p, .madoko h5+p  {
    margin-top: 1ex;
  }
  .madoko h5, .madoko h6 {
    margin-top: 1ex;
    font-size: 1em;
  }
  .madoko h5 {
    margin-bottom: 0.5ex;
  }
  .madoko h5 + p {
    margin-top: 0.5ex;
  }
  .madoko h6 {
    margin-bottom: 0pt;
  }
  .madoko h6 + p {
    margin-top: 0pt;
  }
  .madoko pre, .madoko code, .madoko kbd, .madoko samp, .madoko tt,
  .madoko .monospace, .madoko .token-indent, .madoko .reveal pre, .madoko .reveal code, .madoko .email {
    font-family: Consolas,"Andale Mono WT","Andale Mono",Lucida Console,Monaco,monospace,monospace;
    font-size: 0.85em;
  }
  .madoko pre code, .madoko .token-indent {
    font-size: 0.95em;
  }
  .madoko pre code {
    font-family: inherit !important;
  }
  .madoko ol.linenums li {
    background-color: white;
    list-style-type: decimal;
  }
  .madoko .remote {
    background-color: #F0FFF0;
  }
  .madoko .remote + * {
    margin-top: 0pt;
  }
  @media print {
    body.madoko {
      font-size: 10pt;
    }
    @page {
      margin: 1in 1.5in;
    }
  }
  @media only screen and (max-device-width:1024px) {
    body.madoko {
      padding: 0em 0.5em;
    }
    .madoko li {
      text-align: left;
    }
  }
  
    </style>
  </head>
<body class="madoko">

<div class="body madoko" style="line-adjust:0">

<div class="titleblock align-center para-block" data-line="6" style="text-align:center;line-adjust:0">
<div class="titleheader align-center" data-line="6" style="text-align:center;line-adjust:0">
<div class="title para-block" data-line="6" style="font-size:xx-large;font-weight:bold;margin-bottom:0.5ex;line-adjust:0"><span data-line="6"></span>Managing Bipolar in a Woman of Child Bearing Potential</div></div>
<div class="authors align-center" data-line="11" style="text-align:center;width:80%;line-adjust:0"><table class="authorrow columns block" data-line="11" style="margin-top:2ex;width:100%;line-adjust:0">
<tbody><tr><td class="author column" data-line="11" style="text-align:center;line-adjust:0">
<div class="authorname" data-line="11" style="font-size:large;line-adjust:0"><span data-line="11"></span>Dr. Jagdish Varma</div>
<div class="authoraddress" data-line="14" style="line-adjust:0"><span data-line="14"></span>Professor of Psychiatry, Bhaikaka University, Karamsad</div></td></tr></tbody></table></div></div><span data-line="8"></span>
<nav class="toc toc-contents"><h2 id="sec-contents" class="clearnum h1 heading-contents" data-heading-depth="1" style="display:block">Contents</h2>
<div class="tocblock tocblock1">
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-context" data-toc-depth="1" data-toc-line="[1]{.heading-label}.&#8194;Context" style="toctarget:sec-context"><a href="#sec-context" class="localref"><span class="heading-label">1</span>.&#8194;Context</a></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-maudsley-13th-ed-review-and-case-resolution" data-toc-depth="1" data-toc-line="[2]{.heading-label}.&#8194;Maudsley 13th ed review and case resolution" style="toctarget:sec-maudsley-13th-ed-review-and-case-resolution"><a href="#sec-maudsley-13th-ed-review-and-case-resolution" class="localref"><span class="heading-label">2</span>.&#8194;Maudsley 13th ed review and case resolution</a></div>
<div class="tocblock tocblock2">
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-treatment-with-ms" data-toc-depth="2" data-toc-line="[2.1]{.heading-label}.&#8194;Treatment with MS" style="toctarget:sec-treatment-with-ms"><a href="#sec-treatment-with-ms" class="localref"><span class="heading-label">2.1</span>.&#8194;Treatment with MS</a></div>
<div class="tocblock tocblock3">
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-lithium-li" data-toc-depth="3" data-toc-line="[2.1.1]{.heading-label}.&#8194;Lithium (Li)" style="toctarget:sec-lithium-li"><a href="#sec-lithium-li" class="localref"><span class="heading-label">2.1.1</span>.&#8194;Lithium (Li)</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-mood-stabilizers-cbz-and-valp" data-toc-depth="3" data-toc-line="[2.1.2]{.heading-label}.&#8194;Mood stabilizers (CBZ and VALP)" style="toctarget:sec-mood-stabilizers-cbz-and-valp"><a href="#sec-mood-stabilizers-cbz-and-valp" class="localref"><span class="heading-label">2.1.2</span>.&#8194;Mood stabilizers (CBZ and VALP)</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-ms-lamotrigine" data-toc-depth="3" data-toc-line="[2.1.3]{.heading-label}.&#8194;MS (Lamotrigine)" style="toctarget:sec-ms-lamotrigine"><a href="#sec-ms-lamotrigine" class="localref"><span class="heading-label">2.1.3</span>.&#8194;MS (Lamotrigine)</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-antipsychotic" data-toc-depth="3" data-toc-line="[2.1.4]{.heading-label}.&#8194;Antipsychotic" style="toctarget:sec-antipsychotic"><a href="#sec-antipsychotic" class="localref"><span class="heading-label">2.1.4</span>.&#8194;Antipsychotic</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-depressive-episode" data-toc-depth="3" data-toc-line="[2.1.5]{.heading-label}.&#8194;Depressive episode" style="toctarget:sec-depressive-episode"><a href="#sec-depressive-episode" class="localref"><span class="heading-label">2.1.5</span>.&#8194;Depressive episode</a></div></div></div></div></nav><h2 id="sec-context" class="h1" data-line="10" data-heading-depth="1" style="display:block"><span data-line="10"></span><span class="heading-before"><span class="heading-label">1</span>.&#8194;</span><span data-line="10"></span>Context</h2>
<ul class="ul list-dash compact" data-line="11">
<li class="li ul-li list-dash-li compact-li" data-line="11"><span data-line="11"></span>Case of 28 y/o, married, female, with pre-obese status. 
</li>
<li class="li ul-li list-dash-li compact-li" data-line="12"><span data-line="12"></span>At the time of first episode the patient was unmarried and had presented with euphoric mania, with family h/o of bipolar in brother and h/o good response to lithium in brother<span data-line="12"></span>&#39;<span data-line="12"></span>s case. 
</li>
<li class="li ul-li list-dash-li compact-li" data-line="13"><span data-line="13"></span>1st episode was treated with Lithium and pt showed good response. She was continued on Lithium prophylaxis for 2-3 years. She stopped taking same since 6 months after she got married and moved to UP with her spouse. 
</li>
<li class="li ul-li list-dash-li compact-li" data-line="14"><span data-line="14"></span>2nd episode since 15 days, hypomanic, ppt with psychosocial stressor.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="15"><span data-line="15"></span><strong class="strong-star2">Clinical question</strong><span data-line="15"></span> is whether to start Lithium / another MS / MS  antipsychotic in this pt with active married life, UPT done today negative, but potential of bearing pregnancy in near future. 
</li></ul>
<h2 id="sec-maudsley-13th-ed-review-and-case-resolution" class="h1" data-line="17" data-heading-depth="1" style="display:block"><span data-line="17"></span><span class="heading-before"><span class="heading-label">2</span>.&#8194;</span><span data-line="17"></span>Maudsley 13th ed review and case resolution</h2>
<ul class="ul list-dash compact" data-line="18">
<li class="li ul-li list-dash-li compact-li" data-line="18"><span data-line="18"></span>We have to treat her as if a pregnant woman
</li>
<li class="li ul-li list-dash-li compact-li" data-line="19"><span data-line="19"></span>Risk of relapse during pregnancy if mood‐stabilizing medication is discontinued is high
</li>
<li class="li ul-li list-dash-li compact-li" data-line="20"><span data-line="20"></span>The risks of not stabilizing mood include:

<ul class="ul list-dash compact" data-line="21">
<li class="li ul-li list-dash-li compact-li" data-line="21"><span data-line="21"></span>harm to the mother through poor self‐care, lack of obstetric care or self‐harm
</li>
<li class="li ul-li list-dash-li compact-li" data-line="22"><span data-line="22"></span>harm to the fetus or neonate (ranging from neglect to infanticide).
</li></ul></li></ul>
<h3 id="sec-treatment-with-ms" class="h2" data-line="24" data-heading-depth="2" style="display:block"><span data-line="24"></span><span class="heading-before"><span class="heading-label">2.1</span>.&#8194;</span><span data-line="24"></span>Treatment with MS</h3><h4 id="sec-lithium-li" class="h3" data-line="26" data-heading-depth="3" style="display:block"><span data-line="26"></span><span class="heading-before"><span class="heading-label">2.1.1</span>.&#8194;</span><span data-line="26"></span>Lithium (Li)</h4>
<ul class="ul list-dash compact" data-line="27">
<li class="li ul-li list-dash-li compact-li" data-line="27"><span data-line="27"></span>crosses the placenta 
</li>
<li class="li ul-li list-dash-li compact-li" data-line="28"><span data-line="28"></span>Ebstein<span data-line="28"></span>&#39;<span data-line="28"></span>s anomaly in fetus 
</li>
<li class="li ul-li list-dash-li compact-li" data-line="29"><span data-line="29"></span>Risk of malformations is overestimated
</li>
<li class="li ul-li list-dash-li compact-li" data-line="30"><span data-line="30"></span>NICE recommends that if lithium is considered essential in a woman planning pregnancy, the woman be informed of the risk of fetal malformations and the risk of toxicity in the baby if lithium is continued during breastfeeding.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="31"><span data-line="31"></span>Hence, in this case <span data-line="31"></span><strong class="strong-star2">lithium was not recommended</strong><span data-line="31"></span>
</li></ul>
<h4 id="sec-mood-stabilizers-cbz-and-valp" class="h3" data-line="33" data-heading-depth="3" style="display:block"><span data-line="33"></span><span class="heading-before"><span class="heading-label">2.1.2</span>.&#8194;</span><span data-line="33"></span>Mood stabilizers (CBZ and VALP)</h4>
<ul class="ul list-dash compact" data-line="34">
<li class="li ul-li list-dash-li compact-li" data-line="34"><span data-line="34"></span>Both CBZ and VALP have a clear causal link with increased risk of a variety of fetal abnormalities, particularly neural tube defects including spina bifida.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="35"><span data-line="35"></span>NICE advises against the use of valproate in pregnancy
</li>
<li class="li ul-li list-dash-li compact-li" data-line="36"><span data-line="36"></span>NICE advises discussing the possibility of stopping carbamazepine if a woman is planning a pregnancy or becomes pregnant
</li>
<li class="li ul-li list-dash-li compact-li" data-line="37"><span data-line="37"></span>Hence, in this case <span data-line="37"></span><strong class="strong-star2">Carbamazepine and Valproate were not recommended</strong><span data-line="37"></span>
</li></ul>
<h4 id="sec-ms-lamotrigine" class="h3" data-line="39" data-heading-depth="3" style="display:block"><span data-line="39"></span><span class="heading-before"><span class="heading-label">2.1.3</span>.&#8194;</span><span data-line="39"></span>MS (Lamotrigine)</h4>
<ul class="ul list-dash compact" data-line="40">
<li class="li ul-li list-dash-li compact-li" data-line="40"><span data-line="40"></span>There is growing evidence that lamotrigine is safer in pregnancy than carbamazepine or valproate across a range of outcomes. 
</li>
<li class="li ul-li list-dash-li compact-li" data-line="41"><span data-line="41"></span>However, clearance of lamotrigine seems to increase radically during pregnancy and then reduces post partum so frequent lamotrigine levels are necessary.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="42"><span data-line="42"></span>This may become cumbersome if lamotrigine has to be continued during pregnancy.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="43"><span data-line="43"></span>Also, Lamotrigine does not have anti-manic potential, hence in this case <span data-line="43"></span><strong class="strong-star2">lamotrigine was not recommended</strong><span data-line="43"></span> 
</li></ul>
<h4 id="sec-antipsychotic" class="h3" data-line="45" data-heading-depth="3" style="display:block"><span data-line="45"></span><span class="heading-before"><span class="heading-label">2.1.4</span>.&#8194;</span><span data-line="45"></span>Antipsychotic</h4>
<ul class="ul list-dash compact" data-line="46">
<li class="li ul-li list-dash-li compact-li" data-line="46"><span data-line="46"></span>NICE recommends the <span data-line="46"></span><strong class="strong-star2">use of mood‐stabilizing antipsychotics as a preferable alternative</strong><span data-line="46"></span> to continuation with a mood stabilizer.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="47"><span data-line="47"></span>In acute mania in pregnancy use an antipsychotic and if this is ineffective consider ECT.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="48"><span data-line="48"></span>NICE recommends <span data-line="48"></span><strong class="strong-star2">avoiding depot preparations and anticholinergic drugs</strong><span data-line="48"></span> in pregnancy unless a depot is needed to keep a woman well through the perinatal period.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="49"><span data-line="49"></span>CAVEATS<span data-line="49"></span> <span data-line="49"></span>- Be aware that drug‐induced hyperprolactinaemia may prevent pregnancy. Consider switching to an alternative drug if hyperprolactinaemia occurs and a pregnancy is planned.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="50"><span data-line="50"></span>The most reproductive safety data are available for <span data-line="50"></span><strong class="strong-star2">quetiapine, olanzapine, risperidone and haloperidol</strong><span data-line="50"></span>, with more limited data for <span data-line="50"></span><strong class="strong-star2">clozapine, aripiprazole and ziprasidone</strong><span data-line="50"></span>.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="51"><span data-line="51"></span>Hence, in this case <span data-line="51"></span><strong class="strong-star2">olanzapine was recommended</strong><span data-line="51"></span> with plan to later shift to Arip once acute phase is controlled considering pre-obese status 
</li></ul>
<h4 id="sec-depressive-episode" class="h3" data-line="53" data-heading-depth="3" style="display:block"><span data-line="53"></span><span class="heading-before"><span class="heading-label">2.1.5</span>.&#8194;</span><span data-line="53"></span>Depressive episode</h4>
<ul class="ul list-dash compact" data-line="54">
<li class="li ul-li list-dash-li compact-li" data-line="54"><span data-line="54"></span>In bipolar depression during pregnancy use cognitive behavioural therapy (CBT) for moderate depression and an SSRI for more severe depression. Lamotrigine is also an option.
</li></ul>
<span data-line=""></span></div>
</body>

</html>
